Published in Arch Intern Med on May 25, 1998
The Norwegian General Practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patients. A modified Delphi study. Scand J Prim Health Care (2009) 1.56
Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs. J Clin Invest (2001) 1.45
Drug interactions in general dental practice--considerations for the dental practitioner. Br Dent J (2014) 1.40
Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study. Osteoporos Int (2010) 1.17
Use of anti-depressants and the risk of fracture of the hip or femur. Osteoporos Int (2009) 1.08
Treatment for chronic heart failure in the elderly: current practice and problems. Heart Fail Rev (2013) 0.93
Understanding the NSAID related risk of vascular events. BMJ (2006) 0.91
Selective COX-2 inhibitors, NSAIDs and congestive heart failure: differences between new and recurrent cases. Br J Clin Pharmacol (2008) 0.88
Use of beta2 agonists and risk of acute myocardial infarction in patients with hypertension. Br J Clin Pharmacol (2008) 0.85
Use of non-steroidal anti-inflammatory drugs and risk of incident myocardial infarction and heart failure, and all-cause mortality in the Australian veteran community. Br J Clin Pharmacol (2010) 0.85
Cardiovascular risk with cyclooxygenase inhibitors: general problem with substance specific differences? Naunyn Schmiedebergs Arch Pharmacol (2006) 0.83
Non-steroidal anti-inflammatory drugs and risk of first hospital admission for heart failure in the general population. Heart (2006) 0.81
Knee arthroplasty and risk of hip fracture: a population-based, case-control study. Calcif Tissue Int (2011) 0.80
Management of end stage cardiac failure. Postgrad Med J (2007) 0.79
Non-steroidal anti-inflammatory drugs: use and co-treatment with potentially interacting medications in the elderly. Eur J Clin Pharmacol (2010) 0.79
Loop Diuretics in Clinical Practice. Electrolyte Blood Press (2015) 0.78
Heart failure: Part II. West J Med (1999) 0.75
Non-Steroidal Anti-Inflammatory Drugs and Aspirin Therapy for the Treatment of Acute and Recurrent Idiopathic Pericarditis. Pharmaceuticals (Basel) (2016) 0.75
Cardiovascular Risk of Nonsteroidal Anti-Inflammatory Drugs: An Under-Recognized Public Health Issue. Cureus (2017) 0.75
Gender and drug treatment as determinants of mortality in a cohort of heart failure patients. Eur J Epidemiol (2001) 0.75
Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N Engl J Med (2001) 7.85
Epidemiology of fractures in England and Wales. Bone (2001) 5.76
Transmural myocardial infarction with sumatriptan. Lancet (1993) 5.62
Hypoglycaemia associated with use of inhibitors of angiotensin converting enzyme. Lancet (1995) 5.02
Use of oral corticosteroids and risk of fractures. J Bone Miner Res (2000) 4.75
Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med (1999) 3.81
Confounding by indication: an example of variation in the use of epidemiologic terminology. Am J Epidemiol (1999) 3.44
Venous thromboembolism among new users of different oral contraceptives. Lancet (1999) 3.25
A population-based case-cohort study of drug-associated agranulocytosis. Arch Intern Med (1999) 3.11
Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. Eur Heart J (2002) 2.98
Attitudinal survey of voluntary reporting of adverse drug reactions. Br J Clin Pharmacol (1999) 2.78
Impact of dosage frequency on patient compliance. Diabetes Care (1997) 2.43
NSAIDs and incident Alzheimer's disease. The Rotterdam Study. Neurobiol Aging (1999) 2.41
Risk of acute liver injury associated with the combination of amoxicillin and clavulanic acid. Arch Intern Med (1996) 2.29
Antihypertensive drug therapies and the risk of ischemic stroke. Arch Intern Med (2001) 2.24
A region of the Herpesvirus saimiri genome required for oncogenicity. Science (1985) 2.22
Acute myocardial infarction associated with sildenafil. Lancet (1998) 2.21
Incidence and mortality of acute pancreatitis between 1985 and 1995. Scand J Gastroenterol (2000) 2.20
Risk of extrapyramidal syndromes with haloperidol, risperidone, or olanzapine. Ann Pharmacother (2001) 2.14
Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford) (2000) 2.13
Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-life. Arch Intern Med (1995) 2.13
[Neurological symptoms in newborn infants due to the administration of psychopharmacologic agents during pregnancy]. Ned Tijdschr Geneeskd (1993) 2.01
Use of oral corticosteroids in the United Kingdom. QJM (2000) 1.95
Construction of replication-competent Herpesvirus saimiri deletion mutants. J Virol (1984) 1.89
Pharmaco-morbidity linkage: a feasibility study comparing morbidity in two pharmacy based exposure cohorts. J Epidemiol Community Health (1992) 1.81
[Reasons to report or not report side effects of drugs to the national monitoring system in the Netherlands]. Ned Tijdschr Geneeskd (1995) 1.79
An IL-13 promoter polymorphism associated with increased risk of allergic asthma. Genes Immun (1999) 1.75
The use of a large pharmacoepidemiological database to study exposure to oral corticosteroids and risk of fractures: validation of study population and results. Pharmacoepidemiol Drug Saf (2000) 1.70
Course of the international Normalized Ratio in response to oral vitamin K1 in patients overanticoagulated with phenprocoumon. Br J Haematol (1999) 1.69
Conditional identification of phosphate-starvation-response mutants in Arabidopsis thaliana. Planta (2000) 1.68
Absence of jaagsiekte sheep retrovirus DNA and RNA in bronchioloalveolar and conventional human pulmonary adenocarcinoma by PCR and RT-PCR analysis. Hum Pathol (2001) 1.66
Sex differences in the pharmacological treatment of hypertension: a review of population-based studies. J Hypertens (1997) 1.62
Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens. J Immunol (1992) 1.55
Prognostic value of admission glucose and glycosylated haemoglobin levels in acute coronary syndromes. QJM (2006) 1.53
Women with angina pectoris receive less antiplatelet treatment than men. Br J Gen Pract (1999) 1.51
Use of sympathomimetic drugs leads to increased risk of hospitalization for arrhythmias in patients with congestive heart failure. Arch Intern Med (2000) 1.50
Acute myocardial infarction while using the nicotine patch. Chest (1995) 1.50
Bleeding attributed to the intake of paroxetine. Am J Psychiatry (1994) 1.49
Peptides which bind to E-selectin and block neutrophil adhesion. J Biol Chem (1995) 1.48
Incidence of priapism in the general population. Urology (2001) 1.48
Drug-associated anaphylaxis: 20 years of reporting in The Netherlands (1974-1994) and review of the literature. Clin Exp Allergy (1996) 1.47
A gene for dihydrofolate reductase in a herpesvirus. Science (1988) 1.47
Signalling possible drug-drug interactions in a spontaneous reporting system: delay of withdrawal bleeding during concomitant use of oral contraceptives and itraconazole. Br J Clin Pharmacol (1999) 1.46
Non-puerperal lactation associated with antidepressant drug use. Br J Clin Pharmacol (1997) 1.46
Eosinophilia with clozapine. Lancet (1991) 1.45
[Reports of suspected side effects of selective serotonin reuptake inhibitors in Belgium and The Netherlands]. Ned Tijdschr Geneeskd (1996) 1.42
ACE inhibitor-induced angioedema. Incidence, prevention and management. Drug Saf (1998) 1.42
Channeling of three newly introduced antidepressants to patients not responding satisfactorily to previous treatment. J Clin Psychopharmacol (1997) 1.42
Dangers of dietary germanium supplements. Lancet (1990) 1.42
Application of the ATC/DDD methodology to monitor antibiotic drug use. Eur J Clin Microbiol Infect Dis (1998) 1.42
[Liver damage during administration of itraconazole (Trisporal)]. Ned Tijdschr Geneeskd (1993) 1.41
Sumatriptan and chest pain. Lancet (1993) 1.41
Agreement between the pharmacy medication history and patient interview for cardiovascular drugs: the Rotterdam elderly study. Br J Clin Pharmacol (1998) 1.40
A population based case-cohort study of drug-induced anaphylaxis. Br J Clin Pharmacol (1993) 1.40
[Post-asphyctic encephalopathy of the neonate following administration of nalbuphine during childbirth]. Ned Tijdschr Geneeskd (1992) 1.39
A nested case-control study on mortality in users of ibopamine. Neth J Med (1997) 1.39
Association between oxybutynin and neuropsychiatric adverse effects not confirmed in daily practice. J Am Geriatr Soc (2001) 1.39
Long-term clinical outcome of patients with diabetes proposed for coronary revascularisation. Neth J Med (2006) 1.39
European pharmacovigilance legislation: has it led to implementation of pharmacovigilance inspections? Pharmacoepidemiol Drug Saf (2001) 1.38
[Anaphylaxis caused by chlorhexidine following cystoscopy or urethral catheterization]. Ned Tijdschr Geneeskd (1994) 1.38
[Chest pain due to sumatriptan]. Ned Tijdschr Geneeskd (1992) 1.38
[Adrenal cortex suppression attributed to the use of budesonide]. Ned Tijdschr Geneeskd (1994) 1.38
[Risk of hemorrhage with the use of fluoxetine (Prozac) or fluvoxamine (Fevarin)]. Ned Tijdschr Geneeskd (1993) 1.38
Detecting drug-drug interactions using a database for spontaneous adverse drug reactions: an example with diuretics and non-steroidal anti-inflammatory drugs. Eur J Clin Pharmacol (2000) 1.37
Characterization of two classes of ribonucleoprotein complexes possibly involved in RNA editing from Leishmania tarentolae mitochondria. EMBO J (1994) 1.36
Tendon disorders attributed to fluoroquinolones: a study on 42 spontaneous reports in the period 1988 to 1998. Arthritis Rheum (2001) 1.35
Antihypertensive drugs and incidence of dementia: the Rotterdam Study. Neurobiol Aging (2001) 1.34
Covalent dimerization of vascular permeability factor/vascular endothelial growth factor is essential for its biological activity. Evidence from Cys to Ser mutations. J Biol Chem (1994) 1.33
Coronary vasospasm and sumatriptan. BMJ (1992) 1.33
Immediate coronary angioplasty versus intravenous streptokinase in acute myocardial infarction: left ventricular ejection fraction, hospital mortality and reinfarction. J Am Coll Cardiol (1994) 1.30
Induction of insulin resistance by androgens and estrogens. J Clin Endocrinol Metab (1994) 1.28
Drug-associated acute pancreatitis: twenty-one years of spontaneous reporting in The Netherlands. Am J Gastroenterol (1999) 1.28
A cohort study on the risk of acute liver injury among users of ketoconazole and other antifungal drugs. Br J Clin Pharmacol (1999) 1.26
Thrombocytopenia and leucopenia with mianserin-dependent antibodies. Br J Clin Pharmacol (1985) 1.25
The origin and molecular characterization of adenoid basal carcinoma of the uterine cervix. Int J Gynecol Pathol (1997) 1.24
Incidence of lead dislodgement, malfunction and perforation during the first year following device implantation. Neth Heart J (2014) 1.23
Can adverse drug reactions be detected earlier? A comparison of reports by patients and professionals. BMJ (1996) 1.22
Cardiovascular diseases and risk factors in a population-based study in The Netherlands: agreement between questionnaire information and medical records. Neth J Med (1999) 1.22
Impaired cognitive function and compliance with antihypertensive drugs in elderly: the Rotterdam Study. Clin Pharmacol Ther (2001) 1.20
Achilles tendinitis associated with fluoroquinolones. Br J Clin Pharmacol (1999) 1.18
Carcinosarcomas (malignant mixed mullerian tumors) of the female genital tract: comparative molecular analysis of epithelial and mesenchymal components. Hum Pathol (1998) 1.18
Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study. Osteoporos Int (2010) 1.17